These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7092901)

  • 41. Accumulation of cell-bound alpha-amylase in Bacillus subtilis cells in the presence of tunicamycin.
    Sasaki T; Yamasaki M; Takatsuki A; Tamura G
    Biochem Biophys Res Commun; 1980 Jan; 92(1):334-41. PubMed ID: 6153524
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of tunicamycin and neuraminidase on the expression of Fc-IgM and -IgG receptors on human lymphocytes.
    Itoh K; Kumagai K
    J Immunol; 1980 Apr; 124(4):1830-6. PubMed ID: 6965963
    [No Abstract]   [Full Text] [Related]  

  • 43. Steps in the biosynthesis of mosquito cell membrane glycoproteins and the effects of tunicamycin.
    Butters TD; Hughes RC; Vischer P
    Biochim Biophys Acta; 1981 Feb; 640(3):672-86. PubMed ID: 7213699
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tunicamycin inhibits glycosylation of precursor polyprotein encoded by env gene of Rauscher murine leukemia virus.
    Schultz AM; Oroszlan S
    Biochem Biophys Res Commun; 1979 Feb; 86(4):1206-13. PubMed ID: 435320
    [No Abstract]   [Full Text] [Related]  

  • 45. Toxicity studies of the toxins isolated from annual ryegrass (Lolium rigidum) infected by Corynebacterium rathayi.
    Berry PH; Vogel P
    Aust J Exp Biol Med Sci; 1982 Feb; 60(Pt 1):129-32. PubMed ID: 7092731
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Streptovirudin and tunicamycin, two inhibitors of glycolipid synthesis. Differentiation by use of gel chromatography, H.P.L.C. and hydrolysis.
    Eckardt K; Wetzstein H; Thrum H; Ihn W
    J Antibiot (Tokyo); 1980 Aug; 33(8):908-10. PubMed ID: 7429994
    [No Abstract]   [Full Text] [Related]  

  • 47. Variation in the cytotoxic activities of human dental plaque.
    Levine M; DeLuca C
    Arch Oral Biol; 1978; 23(12):1135-40. PubMed ID: 287431
    [No Abstract]   [Full Text] [Related]  

  • 48. Ultrastructural changes in cerebral blood vessels of sheep injected with tunicamycin.
    Finnie JW; Mukherjee TM
    J Comp Pathol; 1987 Mar; 97(2):217-20. PubMed ID: 3597853
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of solubilization of Salmonella minnesota Re glycolipid on its interferon-induced activity.
    Galabov AS; Eskenazy M; Konstantinov G; Mastikova M
    Experientia; 1979 May; 35(5):598-9. PubMed ID: 446649
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Toxins causing noninflammatory paralytic neuronopathy. Isolation and structure elucidation.
    Dreyer DL; Arai I; Bachman CD; Anderson WR; Smith RG; Daves GD
    J Am Chem Soc; 1975 Aug; 97(17):4985-90. PubMed ID: 1165350
    [No Abstract]   [Full Text] [Related]  

  • 51. Recent advances in chemical ecology.
    Harborne JB
    Nat Prod Rep; 1986 Aug; 3(4):323-44. PubMed ID: 3547185
    [No Abstract]   [Full Text] [Related]  

  • 52. Cytotoxic principles from the sap of Kalmia latifolia.
    Mancini SD; Edwards JM
    J Nat Prod; 1979; 42(5):483-8. PubMed ID: 521818
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neurologic disease produced by
    Finnie J
    Hum Exp Toxicol; 2023; 42():9603271231165672. PubMed ID: 37133421
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical detoxification: elimination of persistent toxicants from the human body.
    Genuis SJ; Sears ME; Schwalfenberg G; Hope J; Bernhoft R
    ScientificWorldJournal; 2013; 2013():238347. PubMed ID: 23844383
    [No Abstract]   [Full Text] [Related]  

  • 55. Benefits and Pitfalls of a Glycosylation Inhibitor Tunicamycin in the Therapeutic Implication of Cancers.
    Banerjee S; Ansari AA; Upadhyay SP; Mettman DJ; Hibdon JR; Quadir M; Ghosh P; Kambhampati A; Banerjee SK
    Cells; 2024 Feb; 13(5):. PubMed ID: 38474359
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Selective catalytic hydrogenation of the N-acyl and uridyl double bonds in the tunicamycin family of protein N-glycosylation inhibitors.
    Price NP; Jackson MA; Vermillion KE; Blackburn JA; Li J; Yu B
    J Antibiot (Tokyo); 2017 Dec; 70(12):1122-1128. PubMed ID: 29089601
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Single-channel analysis of the anion channel-forming protein from the plant pathogenic bacterium Clavibacter michiganense ssp. nebraskense.
    Schürholz T; Dloczik L; Neumann E
    Biophys J; 1993 Jan; 64(1):58-67. PubMed ID: 19431871
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anion channel forming activity from the plant pathogenic bacterium Clavibacter michiganense ssp. nebraskense.
    Schürholz T; Wilimzig M; Katsiou E; Eichenlaub R
    J Membr Biol; 1991 Jul; 123(1):1-8. PubMed ID: 1723101
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glycolipid toxins from parasitised annual ryegrass: a comparison with tunicamycin.
    Vogel P; Stynes BA; Coackley W; Yeoh GT; Petterson DS
    Biochem Biophys Res Commun; 1982 Apr; 105(3):835-40. PubMed ID: 7092901
    [No Abstract]   [Full Text] [Related]  

  • 60. Inhibition of glycosylation by corynetoxin, the causative agent of annual ryegrass toxicity: a comparison with tunicamycin.
    Jago MV; Payne AL; Peterson JE; Bagust TJ
    Chem Biol Interact; 1983 Jul; 45(2):223-34. PubMed ID: 6309418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.